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Despite the lack of consensus regarding the optimalmanagement strategy after a presumed paradoxic em-bolism through a patent foramen ovale (PFO), percu-taneous device closure is used frequently for second-
ary prevention in these patients.1,2 This report describes the first
histologically proven case of a symptomatic device thrombosis as
a result of a chronic inflammatory foreign body response to a PFO
closure device.
Clinical Summary
A 48-year-old woman presented to the emergency department with
signs of a completed stroke. Five hours before admission, hemihyp-
esthesia and weakness developed on her right side. She had received
a percutaneous occlusion (28-mm CardioSEAL device; NMT Medi-
cal, Boston, Mass) of her PFO after a cryptogenic cerebrovascular
event 2 months earlier. She was discharged and prescribed Aspirin
(100 mg once daily) the day after the intervention. Laboratory tests for
hypercoagulable states showed normal results during the first evalu-
ation and on readmittance. Neither diffusion-weighted magnetic res-
onance imaging of the brain nor ultrasound examination of the brain
supplying arteries revealed pathologic findings. An urgent transesoph-
ageal echocardiographic study demonstrated 2 large pedunculated
thrombi on the left atrial disk of the CardioSEAL device (Figure 1).
An electrocardiogram showed ectopic atrial beats. The patient was
first administered Clopidogrel (75 mg) and low-molecular heparin
(80 mg enoxaparin twice/day). After 10 days she was readmitted with
the same symptoms. The transesophageal echocardiogram docu-
mented the known thrombi, which had increased in size. The device
and thrombotic material were surgically removed, and the defect was
closed without complications. Histologic examination detected a
marked foreign body reaction at the Dacron-tissue interface (Figure 2).
Discussion
At present, the CardioSEAL and Amplatzer (AGA Medical Corp,
Golden Valley, Minn) occluders are approved under humanitarian
device regulations by the US Food and Drug Administration for
PFO closure in patients who have had multiple strokes and in
whom conventional drug therapy with warfarin has failed. The
most commonly reported complications after percutaneous device
implantation are atrial fibrillation in approximately 6% and throm-
bus formation on the device ranging from 7% to 22% in patients
with the CardioSEAL device, compared with 0% in patients with
the Amplatzer device.1,2 Device design may therefore have an
impact on tissue reaction.
The CardioSEAL device consists of 2 sets of flexible metallic
arms (alloy of nickel and titanium [nitinol]) to which polyester
fabric (Dacron) is attached. The Amplatzer device is a self-
centering double disc made from nitinol wire frame filled with
polyester fabric.
A fast endothelialization without thrombus formation or
marked foreign body reaction is reported for both devices. How-
ever, histologic information about the tissue reaction after device
implantation is limited to animal studies.3,4
Various in vitro and in vivo studies demonstrated that Dacron
may generate a severe implant-host reaction that may induce
thrombus formation or trigger atrial arrhythmias as reported in this
case.5
Although animal studies usually show uncomplicated tissue
ingrowth and endothelialization after device implantation, our case
documents that tissue reaction to the CardioSEAL occluder may be
unpredictable in human hearts and may expose patients to a
life-threatening situation. Further research should be focused on
the application of more biocompatible materials to avoid the
consequences of foreign body response.
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Figure 1. Transesophageal echocardiography 4-chamber view
demonstrating a large mobile thrombus attached to the left atrial
disc of the CardioSEAL (NMT Medical, Boston, Mass) occluder.
LA, Left atrium; RA, right atrium; LV, left ventricle; MV, mitral
valve; CS, CardioSEAL occluder.
Brief Communications
The Journal of Thoracic and Cardiovascular Surgery ● Volume 130, Number 2 591
References
1. Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath
K, et al. Incidence and clinical course of thrombus formation on atrial
septal defect and patent foramen ovale closure devices in 1000 consec-
utive patients. J Am Coll Cardiol. 2004;43:302-9.
2. Anzai H, Child J, Natterson B, Krivokapich J, Fishbein CM, Chan FK,
et al. Incidence of thrombus formation on the CardioSeal and the
Amplatzer interatrial closure devices. Am J Cardiol. 2004;93:426-31.
3. Kuhn MA, Latson LA, Cheatham JP, McManus B, Anderson JM, Kilzer
KM, et al. Biological response to Bard Clamshell septal occluders in the
canine heart. Circulation. 1996;93:1459-63.
4. Lock JE, Rome JJ, Davis R, Van Praagh S, Perry SB, Van Praagh R, et
al. Transcatheter closure of atrial septal defects. Experimental studies.
Circulation. 1989;79:1091-9.
5. Paquay Y, deRuijter JE, van der Waerden J, Jansen J. Tissue reaction to
Dacron velour and titanium fibre mesh used for anchorage of percuta-
neous devices. Biomaterials. 1996;17:1251-6.
Figure 2. Microscopic examination showing a foreign body reaction with granulation tissue (right). Part of the
thrombus (left) (magnification 20). Higher magnification (200) of the granulation tissue with polarizing foreign
material (inset) (stained with trichrome, collagen [blue]; muscle and thrombus [red]).
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